The Global Ophthalmology and Vision Science Congress (GOVIS 2027) is an international gathering dedicated to developments in ophthalmology, vision science, eye care, and related clinical and research disciplines. Scheduled for June 14–16, 2027, the congress will take place in Rome, Italy, with online access available for professionals and researchers worldwide. The Ophthalmology Conference brings together ophthalmologists, optometrists, vision scientists, researchers, healthcare professionals, academics, technology specialists, and industry representatives to exchange knowledge and explore emerging developments in eye health.
Ophthalmology Conference 2027 presents a broad scientific program covering areas such as retinal disorders, glaucoma, cataract care, corneal and refractive developments, pediatric ophthalmology, neuro-ophthalmology, ocular oncology, ocular imaging, and global vision health. Scientific discussions also extend to molecular and genetic ophthalmology, regenerative approaches, ocular therapeutics, drug delivery, visual neuroscience, ophthalmic surgery, advanced devices, and diagnostic technologies. Emerging areas such as artificial intelligence, digital ophthalmology, gene and cell therapies, and innovative treatment strategies add further depth to the program.
Through keynote presentations, scientific sessions, panel discussions, symposia, workshops, oral presentations, poster sessions, and clinical case discussions, GOVIS 2027 creates opportunities for knowledge exchange across different areas of eye research and practice. The Ophthalmology Conferences also provides a platform for researchers and emerging professionals to present their findings and connect with an international scientific community. Abstract submissions relevant to the congress program can be considered for presentation, while accepted contributions are included in the conference proceedings book with a DOI.
With its hybrid format, GOVIS 2027 connects the ophthalmology and vision science community through both in-person and virtual participation, supporting international collaboration and wider access to contemporary developments in eye care.
